| CDK6-AS1 |
|
CDK6 antisense RNA 1
|
|
|
0.861 |
0.115 |
| BLACE |
A4D250
|
B cell acute lymphoblastic leukemia expressed
|
|
|
0.931 |
0.115 |
| RCSD1 |
Q6JBY9
|
RCSD domain containing 1
|
|
3.6E-02 |
0.821 |
0.192 |
| MXD3 |
Q9BW11
|
MAX dimerization protein 3
|
Transcription factor
|
3.1E-03 |
0.743 |
0.231 |
| SNX2 |
O60749
|
sorting nexin 2
|
Transporter
|
0.98 |
0.792 |
0.231 |
| MIR568 |
|
microRNA 568
|
|
|
0.821 |
0.231 |
| IGHV5-78 |
|
immunoglobulin heavy variable 5-78 (pseudogene)
|
|
|
0.839 |
0.231 |
| ALL1 |
|
Leukemia, acute lymphocytic, susceptibility to, 1
|
|
|
0.636 |
0.269 |
| SSBP2 |
P81877
|
single stranded DNA binding protein 2
|
|
1.00 |
0.659 |
0.269 |
| ZNF384 |
Q8TF68
|
zinc finger protein 384
|
|
1.00 |
0.705 |
0.269 |
| TRDC |
B7Z8K6
|
T cell receptor delta constant
|
|
|
0.729 |
0.269 |
| TRDJ1 |
A0A075B706
|
T cell receptor delta joining 1
|
|
|
0.736 |
0.269 |
| TRDD3 |
|
T cell receptor delta diversity 3
|
|
|
0.736 |
0.269 |
| GNA15 |
P30679
|
G protein subunit alpha 15
|
Enzyme modulator
|
6.0E-03 |
0.780 |
0.269 |
| ATP11C |
Q8NB49
|
ATPase phospholipid transporting 11C
|
Transporter
|
1.00 |
0.751 |
0.269 |
| CSRP2 |
Q16527
|
cysteine and glycine rich protein 2
|
Cellular structure
|
4.8E-07 |
0.780 |
0.269 |
| STYXL1 |
Q9Y6J8
|
serine/threonine/tyrosine interacting like 1
|
|
1.3E-08 |
0.839 |
0.269 |
| ETV7 |
Q9Y603
|
ETS variant transcription factor 7
|
Transcription factor
|
4.0E-14 |
0.736 |
0.308 |
| RAB5C |
P51148
|
RAB5C, member RAS oncogene family
|
|
0.94 |
0.736 |
0.308 |
| CDC34 |
P49427
|
cell division cycle 34
|
|
0.96 |
0.705 |
0.308 |
| LCP2 |
Q13094
|
lymphocyte cytosolic protein 2
|
Signaling
|
0.92 |
0.716 |
0.308 |
| FZD9 |
O00144
|
frizzled class receptor 9
|
G-protein coupled receptor
|
1.9E-03 |
0.743 |
0.308 |
| DDX23 |
Q9BUQ8
|
DEAD-box helicase 23
|
|
0.54 |
0.821 |
0.308 |
| IGL |
|
immunoglobulin lambda locus
|
|
|
0.659 |
0.346 |
| RASSF10 |
A6NK89
|
Ras association domain family member 10
|
|
|
0.626 |
0.385 |